MOHMOHHealthcare · Healthcare Plans

MOH Stock Forecast: Molina Healthcare, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$212
+3.27% on the day

The 19 Wall Street analysts covering Molina Healthcare, Inc. hold a median 12-month price target of $209 — -1.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 13 Aug 2026 — in the lower half.

Market cap
$10.8B
Ticker Nerd rank
31 / 100
Median analyst target
$209
Analysts covering
19
Total return, dividends reinvested
1W
+8.1%
1M
−12.1%
YTD
+22.4%
1Y
+33.1%
From 52W high
−12.5%
From 52W low
+73.2%
$123
$243
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MOH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Molina Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
84
Value
67
Issuance
66
Revisions
53
Accruals
47
Momentum
35
Growth
26
Quality
20
Size
15

Volatility (84): The share price has been relatively steady.

Quality (20): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MOH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MOH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$150$200$250Oct 25Jan 26Apr 26Jul 26MOHHigh $266Median $209Low $147

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says19 analysts
3 Buy15 Hold1 Sell
Low $147Median $209High $266

The green dot is the last close — the median target sits −1.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
28 July 2026Wells FargoMaintainsEqual-Weight$235$220
24 July 2026BarclaysMaintainsUnderweight$184$180
24 July 2026RBC CapitalMaintainsSector Perform$248$218
24 July 2026Truist SecuritiesMaintainsHold$250$225
14 July 2026TD CowenMaintainsHold
14 July 2026TD CowenMaintainsHold$163$230
14 July 2026Truist SecuritiesMaintainsHold$205$250
14 July 2026Truist SecuritiesMaintainsHold
13 July 2026Wells FargoMaintainsEqual-Weight$159$235
13 July 2026Wells FargoMaintainsEqual-Weight
9 July 2026BarclaysMaintainsUnderweight$199$184
9 July 2026BarclaysMaintainsUnderweight
9 July 2026RBC CapitalMaintainsSector Perform
9 July 2026RBC CapitalMaintainsSector Perform$216$248
23 June 2026RBC CapitalInitiatesSector Perform
8 June 2026JP MorganMaintainsNeutral
4 June 2026Morgan StanleyMaintainsEqual-Weight
26 May 2026BarclaysMaintainsUnderweight
22 May 2026UBSMaintainsNeutral
11 May 2026BairdMaintainsNeutral

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MOH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

MOH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.2%
Analysts raising
10
Analysts cutting
5
Fundamentals

Molina Healthcare, Inc. (MOH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
1288.1×

Cheaper than 1% of US stocks

Price / sales
0.3×

Cheaper than 91% of US stocks

Price / book
2.6×

Cheaper than 39% of US stocks

EV / EBITDA
13.3×

Cheaper than 28% of US stocks

Growth & margins
Revenue growth (YoY)
−5.7%

Higher than 19% of US stocks

Earnings growth (YoY)
−76.5%

Higher than 5% of US stocks

Gross margin
8.5%

Higher than 9% of US stocks

Operating margin
1.4%

Higher than 48% of US stocks

Net margin
−0.0%

Higher than 30% of US stocks

Returns & dividend
Return on equity
−0.2%

Higher than 44% of US stocks

Return on assets
1.2%

Higher than 51% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

MOH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
MOHMolina Healthcare, Inc.$10.8B
31
OSCROscar Health, Inc.$9.2B
83
CNCCentene Corp.$32.5B
91
ALHCAlignment Healthcare, Inc.$2.7B
69
HUMHumana, Inc.$46.3B
44
CLOVClover Health Investments Corp.$2.3B
67
PGNYProgyny, Inc.$2.0B
97

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Molina Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MOH news & analysis

Health insurers are dumping Medicare Advantage plans. Here's how many seniors could be affected.

Market Watch · 11 Aug 2026neutral

Health insurers are dropping Medicare Advantage plans, which could leave many older adults seeking new coverage next year, particularly in rural markets with fewer insurance options. The excerpt notes that seniors could face scrambling to find alternative health coverage.

Why it matters — Molina Healthcare offers Medicare Advantage coverage, so industry-wide plan exits signal potential churn and reduced options in the markets it serves.

Molina Healthcare: Management Has Made The Difficult Decision For Long-Term Benefit

Seeking Alpha · 29 July 2026positive

A Seeking Alpha analysis highlighted that Molina Healthcare's management is addressing ACA underperformance while its Medicaid segment continues to outperform peers, characterizing the strategic moves as difficult decisions made for long-term benefit.

Why it matters — MOH watchers would care because the company's strategic adjustments to its ACA business and strong Medicaid performance could shape its competitive position and operational trajectory.

Are Investors Undervaluing Molina Healthcare (MOH) Right Now?

Zacks Investment Research · 24 July 2026positive

Zacks Investment Research published a piece questioning whether investors are undervaluing Molina Healthcare (MOH). The article highlights the Zacks Rank system, which focuses on earnings estimates and estimate revisions to identify strong stocks.

Why it matters — MOH watchers would care because the article suggests the stock may currently be undervalued based on the metrics the Zacks system tracks.

Molina Healthcare, Inc. (MOH) Q2 2026 Earnings Call Transcript

Seeking Alpha · 24 July 2026neutral

Molina Healthcare held its Q2 2026 earnings call, and a transcript of the call has been published by Seeking Alpha.

Why it matters — A MOH watcher would care because earnings call transcripts provide detailed insight into the company's quarterly performance and management's outlook.

FAQ

Frequently asked questions about MOH stock

What is the MOH stock price forecast for 2026-2027?

The 19 Wall Street analysts covering Molina Healthcare, Inc. have a median 12-month price target of $209, with estimates ranging from $147 to $266. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MOH stock a buy right now?

Of the 19 analysts covering Molina Healthcare, Inc., 3 rate it a Buy, 15 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Molina Healthcare, Inc. 31 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MOH?

As at 13 Aug 2026, Molina Healthcare, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (84 of 100).

Will MOH stock go up?

No one can know that. What the data says: the median 12-month target from 19 analysts implies -1.6% from the last close, and Ticker Nerd's factor model ranks Molina Healthcare, Inc. 31 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MOH stock forecast for 2030?

No analyst covering Molina Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MOH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $147 to $266 over the next 12 months.

How has MOH stock performed over the past year?

Molina Healthcare, Inc. returned +33.1% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Molina Healthcare, Inc. do?

Molina Healthcare Inc. is a managed care company that provides government-focused health insurance and related services in the United States.

What is the latest news on MOH?

The most recent item we track (Market Watch, 11 Aug 2026): "Health insurers are dumping Medicare Advantage plans. Here's how many seniors could be affected.". Health insurers are dropping Medicare Advantage plans, which could leave many older adults seeking new coverage next year, particularly in rural markets with fewer insurance options. The excerpt notes that seniors could face scrambling to find alternative health coverage.

Company

About Molina Healthcare, Inc.

Molina Healthcare Inc. is a managed care company that provides government-focused health insurance and related services in the United States. The company primarily serves low-income families and individuals through comprehensive health plans across Medicaid, Medicare, and state-based Marketplace segments. Molina Healthcare partners with state and federal agencies to administer benefits, manage medical costs, and coordinate care for members, often acting as an intermediary between public programs and healthcare providers. Its offerings typically include physician and hospital services, prescription drug coverage, behavioral health, and preventive care, with an emphasis on network management and care management programs. Molina Healthcare plays a significant role in the healthcare plans industry by focusing on underserved populations and complex government-sponsored programs, contributing to the broader stability and accessibility of the U.S. healthcare system. Headquartered in Long Beach, California, and founded in 1980, the company operates across multiple states through its various health plan subsidiaries.

CEO Mr. Joseph Michael Zubretsky · 19,000 employees · United States · https://www.molinahealthcare.com